首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1441277

全球試紙診斷市場規模、佔有率、成長分析（按產品類型、設備類型）- 產業預測，2023-2030 年

Global Paper Diagnostics Market Size, Share, Growth Analysis, By Product(Lateral Flow Assays, Dipsticks), By Device Type(Diagnostic Devices, Monitoring Devices) - Industry Forecast 2023-2030

出版日期: 2024年02月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球試紙診斷市場規模預估為83.5億美元，預計將從2023年的 90.2 億美元成長到2031年的 166.9 億美元，預測期內（2024-2031年）年複合成長率為 8%。

作為可攜式且經濟高效的照護現場檢測選擇，試紙診斷市場經歷顯著成長。這些設備在試紙基材上進行醫學測試，可以快速且準確地進行診斷，這在偏遠和資源有限的地區尤其有益。由於易於使用、設備要求最低以及檢測瘧疾、愛滋病毒和糖尿病等疾病的有效性等優勢，該市場不斷成長。試紙診斷具有生產成本低、易於處置、無需專業人員的優點。應用包括環境監測、食品安全檢測和臨床診斷。對即時、分散醫療服務的需求日益增加，特別是在服務不足的地區，這推動試紙診斷的普及。隨著技術的進步，微流體、與感測器的整合以及與智慧型手機的兼容性增加了這種潛力。然而，挑戰仍然存在，例如確保結果的穩健性和準確性，在不同條件下保持穩定性以及擴大可檢測分析物的範圍。透過持續的研究、製造流程的改進以及醫療保健提供者、學術機構和行業相關人員之間不斷加強的合作，試紙診斷市場預計將繼續保持上升趨勢。試紙解決方案為實現世界經濟實惠且快速診斷的目標提供了一條充滿希望的道路。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東、非洲
- 海灣合作理事會國家
- 南非
- 其他中東、非洲地區

競爭格局

前5名企業比較
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Becton, Dickinson and Company（BD）
Siemens Healthineers
bioMerieux
Mologic Ltd.
Diagnostics For All
Micronics
Alere Inc.（Now part of Abbott）
EKF Diagnostics
Nova Biomedical
Zoetis Inc.
Abaxis（Part of Zoetis）
Cytodiagnostics Inc.
Bio-Rad Laboratories, Inc.
ACON Laboratories, Inc.
CellFree Sciences Co., Ltd.

簡介目錄

Product Code: SQMIG35H2179

Global Paper Diagnostics Market size was valued at USD 8.35 Billion in 2022 and is poised to grow from USD 9.02 Billion in 2023 to USD Billion 16.69 by 2031, at a CAGR of 8% during the forecast period (2024-2031).

The paper diagnostics market has seen remarkable growth as a portable and cost-effective option for point-of-care testing. These devices conduct medical tests on paper-based substrates, offering swift and precise diagnoses, particularly beneficial in remote or resource-limited areas. The market is expanding due to its advantages, such as ease of use, minimal equipment requirements, and effectiveness in detecting diseases like malaria, HIV, and diabetes. Paper diagnostics offer benefits such as low manufacturing costs, easy disposal, and reduced need for specialized personnel. They find applications in environmental monitoring, food safety testing, and clinical diagnostics. The increasing demand for immediate, decentralized healthcare, especially in underserved regions, has propelled the popularity of paper diagnostics. As technology progresses, integration with microfluidics, sensors, and compatibility with smartphones enhance their potential. Challenges persist, including ensuring the robustness and accuracy of results, maintaining stability under diverse conditions, and broadening the scope of detectable analytes. Through ongoing research, improved manufacturing processes, and growing collaborations between healthcare providers, academic institutions, and industry players, the paper diagnostics market is anticipated to continue its upward trajectory. Paper-based solutions offer a promising avenue to meet the global goal of affordable and rapid diagnostic accessibility.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Paper Diagnostics and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Paper Diagnostics Market Segmental Analysis

The Paper Diagnostics Market is segmented by product, device type, application, end-use, and region. Based on product the market is segmented as lateral flow assays, dipsticks, and paper based microfluidics. Based on device type the market is segmented as, diagnostic devices, monitoring devices. Based on application the market is segmented as, clinical diagnostics, cancer, infectious diseases, liver disorders, other, food quality testing, and environmental monitoring. Based on end-use the market is segmented as, home healthcare, assisted living healthcare facilities, hospital and clinics, and others. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA).

Drivers of the Global Paper Diagnostics Market

Paper diagnostics facilitate quick and cost-effective point-of-care testing, enabling swift diagnosis and treatment, particularly in resource-limited or rural areas where standard laboratory facilities are lacking.

Paper-based devices are an attractive option due to their relatively low manufacturing costs, which is especially beneficial in regions with limited healthcare budgets or high patient volumes.

Restraints in the Global Paper Diagnostics Market

The entrenched use of traditional diagnostic methods within healthcare systems poses challenges for paper diagnostics to complement or substitute them in certain scenarios.

There may be a need to educate and gain acceptance from healthcare professionals and patients before widespread adoption of paper diagnostics, particularly in regions where these technologies are less familiar.

Market Trends of the Global Paper Diagnostics Market

Emergence of Point-of-Care Testing: The adoption of point-of-care testing was spurred by the demand for fast and convenient diagnostic solutions. The shift towards decentralized healthcare aligned with the ability of paper diagnostics to provide rapid results without specialized equipment.

Technological Progress: The functionalities of paper-based devices were enhanced through the integration of microfluidics, smartphone connectivity, and biosensors. These advancements enabled more sophisticated assays, improved accuracy, and enhanced data transfer.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Paper Diagnostics Market by Product

Market Overview
Lateral Flow Assays
Dipsticks
and Paper Based Microfluidics

Global Paper Diagnostics Market by Device Type

Market Overview
Diagnostic Devices
Monitoring Devices

Global Paper Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mologic Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diagnostics For All
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micronics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (Now part of Abbott)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EKF Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nova Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abaxis (Part of Zoetis)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytodiagnostics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CellFree Sciences Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments